Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
2617 items from SEC EDGAR · clear filters
- 8-K - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Filer)
Universal Safety Products filed a Form 8-K reporting a material definitive agreement, a new financial obligation/off-balance-sheet arrangement, unregistered equity sales, and accompanying financial statements and exhibits.
- 8-K - Stagwell Inc (0000876883) (Filer)
Stagwell Inc. filed a Form 8-K reporting that it has submitted certain matters to a vote of its security holders, as disclosed in Item 5.07 of the filing.
- 8-K - Energous Corp (0001575793) (Filer)
Energous Corp filed a Form 8-K reporting the departure and appointment of certain officers, related compensatory arrangements, submission of matters to a shareholder vote, and inclusion of financial statements and exhibits.
- 8-K - Optimum Communications, Inc. (0001702780) (Filer)
Optimum Communications, Inc. filed a Form 8-K on June 12, 2026 indicating that certain matters have been submitted to a vote of its security holders, as disclosed in Item 5.07 of the filing.
- 8-K - DELTA AIR LINES, INC. (0000027904) (Filer)
Delta Air Lines filed a Form 8-K reporting that it has entered into a material definitive agreement and has created a direct financial obligation, including an off-balance-sheet arrangement, as disclosed in Item 1.01 and Item 2.03.
- 8-K - AIR INDUSTRIES GROUP (0001009891) (Filer)
Air Industries Group filed a Form 8-K on June 12, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - OFA Group (0002036307) (Filer)
OFA Group filed a Form 8-K reporting a notice of delisting or failure to satisfy a continued listing rule, a transfer of its listing, other events, and accompanying financial statements and exhibits.
- 8-K - GT Biopharma, Inc. (0000109657) (Filer)
GT Biopharma, Inc. filed an 8-K on June 12, 2026, reporting amendments to its articles of incorporation or bylaws, a change in fiscal year, and providing accompanying financial statements and related exhibits.
- 8-K - ABEONA THERAPEUTICS INC. (0000318306) (Filer)
Abeona Therapeutics Inc. filed a Form 8-K on June 12, 2026, reporting that it has submitted certain matters to a vote of its security holders, as required under Item 5.07.
- 8-K - Seaport Entertainment Group Inc. (0002009684) (Filer)
Seaport Entertainment Group Inc. filed a Form 8-K on June 12, 2026, reporting that it has submitted certain matters to security holders for a vote, as disclosed in Item 5.07 of the filing.
- 8-K - Hut 8 Corp. (0001964789) (Filer)
Hut 8 Corp. filed a Form 8-K on June 12, 2026 indicating that certain matters have been submitted to its security holders for a vote.
- 8-K - GPGI, Inc. (0001823144) (Filer)
GPGI, Inc. filed a Form 8-K on June 12, 2026 indicating that certain matters were submitted to a vote of its security holders, as required under Item 5.07 of the filing.
- 8-K/A - Shoals Technologies Group, Inc. (0001831651) (Filer)
Shoals Technologies Group filed an amendment to its Form 8-K on June 12, 2026, reporting a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.
- 8-K - Playtika Holding Corp. (0001828016) (Filer)
Playtika Holding Corp. filed a Form 8-K on June 12, 2026, reporting that it has submitted certain matters to its security holders for a vote, as required under Item 5.07.
- 8-K - COMCAST CORP (0001166691) (Filer)
Comcast Corp filed an 8-K on June 12, 2026 indicating that certain matters have been submitted to security holders for a vote.
- 8-K - Summit Therapeutics Inc. (0001599298) (Filer)
Summit Therapeutics Inc. filed a Form 8-K on June 12, 2026, reporting that it has submitted certain matters to its security holders for a vote, as required under Item 5.07.
- 8-K - Vor Biopharma Inc. (0001817229) (Filer)
Vor Biopharma Inc. filed a Form 8-K on June 12, 2026, including Item 5.07 regarding matters submitted for a security-holder vote and Item 9.01 containing financial statements and related exhibits.
- 8-K - NN INC (0000918541) (Filer)
NN Inc filed a Form 8-K on June 12, 2026 reporting the departure, election or appointment of certain directors and officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - Solid Power, Inc. (0001844862) (Filer)
Solid Power, Inc. filed a Form 8-K on June 12, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits, referenced by accession number 0001104659-26-073457.
- 8-K - Camp4 Therapeutics Corp (0001736730) (Filer)
Camp4 Therapeutics Corp filed a Form 8-K on June 12, 2026, reporting director/officer departures, elections, appointments, related compensation arrangements, matters submitted for shareholder vote, and accompanying financial statements and exhibits.
- 8-K - OptimizeRx Corp (0001448431) (Filer)
OptimizeRx Corp filed a Form 8-K reporting director/officer departures and appointments, related compensation arrangements, a shareholder vote, and accompanying financial statements and exhibits.
- 8-K - BIOCRYST PHARMACEUTICALS INC (0000882796) (Filer)
Biocryst Pharmaceuticals filed a Form 8-K on June 12, 2026, reporting director and officer departures, elections, compensatory arrangements, shareholder voting matters, and accompanying financial statements and exhibits.
- 8-K/A - Trinseo PLC (0001519061) (Filer)
Trinseo PLC submitted a Form 8-K amendment on June 12, 2026 (Accession No. 0001104659-26-073451), providing its financial statements and related exhibits as required under Item 9.01.
- 8-K - MSD Investment Corp. (0001849894) (Filer)
MSD Investment Corp. filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, other events, and accompanying financial statements and exhibits.
- 8-K - HORMEL FOODS CORP /DE/ (0000048465) (Filer)
Hormel Foods Corp filed a Form 8-K reporting the departure and appointment of certain officers and directors, related compensatory arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - STRATUS PROPERTIES INC (0000885508) (Filer)
Stratus Properties Inc. filed a Form 8-K on June 12, 2026, disclosing entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Filer)
Diversified Healthcare Trust filed a Form 8-K on June 12, 2026, including Item 5.07 regarding matters submitted for a security-holder vote and Item 9.01 containing financial statements and related exhibits.
- 8-K - LENZ Therapeutics, Inc. (0001815776) (Filer)
LENZ Therapeutics, Inc. filed a Form 8-K on June 12, 2026, reporting that it has submitted certain matters to a vote of its security holders, as required under Item 5.07 of the filing.
- 8-K - Service Properties Trust (0000945394) (Filer)
Service Properties Trust filed a Form 8-K reporting director and officer departures, appointments and compensation arrangements, submission of matters to a security-holder vote, and accompanying financial statements and exhibits.
- 8-K - Avalo Therapeutics, Inc. (0001534120) (Filer)
Avalo Therapeutics filed an 8-K reporting unregistered equity sales, modifications to security holder rights, director and officer departures, appointments and compensation arrangements, amendments to its articles, bylaws and fiscal year, and accompanying financial statements.